116 related articles for article (PubMed ID: 23387809)
41. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.
Faria P; Beckwith JB; Mishra K; Zuppan C; Weeks DA; Breslow N; Green DM
Am J Surg Pathol; 1996 Aug; 20(8):909-20. PubMed ID: 8712292
[TBL] [Abstract][Full Text] [Related]
42. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
43. Histopathological variations among cases of Wilms' tumor in Bangladesh and its relationship with prognosis.
Ara T; Khan WA; Ali SM
Bangladesh Med Res Counc Bull; 1997 Aug; 23(2):56-9. PubMed ID: 9465437
[TBL] [Abstract][Full Text] [Related]
44. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
[TBL] [Abstract][Full Text] [Related]
45. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.
Sredni ST; de Camargo B; Lopes LF; Teixeira R; Simpson A
Med Pediatr Oncol; 2001 Nov; 37(5):455-8. PubMed ID: 11745874
[TBL] [Abstract][Full Text] [Related]
47. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
48. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
49. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia.
Li W; Kessler P; Williams BR
Oncogene; 2005 Jan; 24(3):457-68. PubMed ID: 15531917
[TBL] [Abstract][Full Text] [Related]
50. [Anaplastic type of Wilms' tumour].
Vujanić GM; Aleksandrović S
Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
[TBL] [Abstract][Full Text] [Related]
51. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
52. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
[TBL] [Abstract][Full Text] [Related]
53. Cytogenetic findings in Wilms' tumour: a single institute study.
MdZin R; Murch A; Charles A
Pathology; 2010 Dec; 42(7):643-9. PubMed ID: 21080873
[TBL] [Abstract][Full Text] [Related]
54. TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia.
Wegert J; Vokuhl C; Ziegler B; Ernestus K; Leuschner I; Furtwängler R; Graf N; Gessler M
J Pathol Clin Res; 2017 Oct; 3(4):234-248. PubMed ID: 29085664
[TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity at 7p in Wilms' tumour development.
Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
[TBL] [Abstract][Full Text] [Related]
56. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
[TBL] [Abstract][Full Text] [Related]
57. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
[TBL] [Abstract][Full Text] [Related]
58. Synchronous wilms tumor and fibrolamellar hepatocellular carcinoma: report of a case.
Maitra A; Ramnani DM; Margraf LR; Gazdar AF
Pediatr Dev Pathol; 2000; 3(5):492-6. PubMed ID: 10890935
[TBL] [Abstract][Full Text] [Related]
59. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
[TBL] [Abstract][Full Text] [Related]
60. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
